Investment
Features
FeesSafety
Academy
More
Pluang+

Senators urge SEC to probe $3.8B losses in Trump meme coin amid insider trading concerns.

Market News
04 Aug 2026
The Currency Analytics
View Source
Bearish
Senators urge SEC to probe $3.8B losses in Trump meme coin amid insider trading concerns.

Senators Elizabeth Warren and Richard Blumenthal have called on the SEC to investigate Donald Trump's meme coin after nearly a million investors lost over $3.8 billion from its launch in January 2025 to June 2026. Meanwhile, Trump and his family reportedly earned around $636 million from trading fees during the same period, raising concerns about insider trading and unfair profit distribution. The token's value plummeted from over $70 to under $1.50, sparking allegations of a "soft rug pull" and prompting scrutiny of the development team's token sales amid the price decline. The SEC has yet to comment, but the case highlights ongoing regulatory challenges in the crypto space, especially around meme coins and retail investor protection.

More News

Oculis completes patient randomization in trial for precision treatment of TNFR1-mediated dry eye disease

Oculis completes patient randomization in trial for precision treatment of TNFR1-mediated dry eye disease

Oculis Holding AG has completed patient randomization in its PREDICT-1 clinical trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). Two-thirds of the 176 enrolled patients carry a genetic variant linked to...

Market News
Bullish
53 minutes ago
Ekalia partners with Telix to boost astatine-211 production in the US for cancer therapy.

Ekalia partners with Telix to boost astatine-211 production in the US for cancer therapy.

Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate the production of astatine-211 in the United States. Astatine-211 is a promising alpha-emitting radioisotope used in targ...

Market News
Bullish
1 hour ago
Roche unveils pivotal cancer drug data at ESMO 2026, highlighting advances in lung and breast cancer treatments.

Roche unveils pivotal cancer drug data at ESMO 2026, highlighting advances in lung and breast cancer treatments.

At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...

Market News
Bullish
1 hour ago
Red Cat offers €39/share to acquire Steyr Motors, boosting its maritime defense tech and Austrian growth.

Red Cat offers €39/share to acquire Steyr Motors, boosting its maritime defense tech and Austrian growth.

Red Cat Holdings announced a voluntary public purchase offer to acquire all outstanding shares of Steyr Motors AG at €39 per share in cash, representing a significant premium over recent prices. The acquisition aims to strengthen Red Cat's Blue Ops u...

Company Fundamentals
Bullish
1 hour ago
GSK's lung cancer drug shows 61% response rate in early global trial at higher dose

GSK's lung cancer drug shows 61% response rate in early global trial at higher dose

GSK announced that its experimental lung cancer drug, risvutatug rezetecan, achieved a 61% confirmed response rate at the higher 8 mg/kg dose in an early global trial involving patients with relapsed extensive-stage small cell lung cancer. This respo...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App